Virtu Financial’s Nuvation Bio NUVB Stock Holding History

Virtu Financial’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$123K	Buy	+21,642	New	+$106K	﹤0.01%	1067
2024 Q1	–	Sell	-38,661	Closed	-$58K	–	1882
2023 Q4	$58K	Buy	38,661 +1,016	+3%	+$1.31K	﹤0.01%	1150
2023 Q3	$50K	Buy	37,645 +24,091	+178%	+$40.1K	0.01%	903
2023 Q2	$24K	Buy	+13,554	New	+$23K	﹤0.01%	1234
2023 Q1	–	Sell	-16,037	Closed	-$31K	–	1912
2022 Q4	$31K	Buy	+16,037	New	+$32.4K	﹤0.01%	1178
2022 Q3	–	Sell	-32,637	Closed	-$106K	–	2072
2022 Q2	$106K	Buy	+32,637	New	+$142K	0.01%	941
2021 Q2	–	Sell	-37,408	Closed	-$391K	–	1890
2021 Q1	$391K	Buy	+37,408	New	+$418K	0.03%	658

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Virtu Financial's NUVB Position: Q2 2026 in Review

Virtu Financial opened a new position in Nuvation Bio (NUVB) in Q2 2026: 21,642 shares worth $123K. The stake represents ﹤0.01% of the portfolio and ranks #1067 among its holdings. This is a return to the name: Virtu Financial previously reported a position in NUVB as recently as Q4 2023.

Virtu Financial first reported a position in NUVB in Q1 2021 and has held it in 7 quarters since. The position peaked at $391K in Q1 2021. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Virtu Financial held 21,642 shares of Nuvation Bio worth $123K as of Q2 2026.
Nuvation Bio was a new Virtu Financial position in Q2 2026.
Nuvation Bio made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1067 holding.
Virtu Financial first reported a position in Nuvation Bio in Q1 2021 and has held it in 7 quarters since.
Virtu Financial's Nuvation Bio position peaked at $391K in Q1 2021.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.